These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

50 related items for PubMed ID: 8259534

  • 21. Subcutaneous unfractionated heparin for the treatment of venous thromboembolism.
    Kearon C.
    Curr Opin Pulm Med; 2007 Sep; 13(5):398-402. PubMed ID: 17940484
    [Abstract] [Full Text] [Related]

  • 22. Venous thromboembolism in very elderly patients: findings from a prospective registry (RIETE).
    López-Jiménez L, Montero M, González-Fajardo JA, Arcelus JI, Suárez C, Lobo JL, Monreal M, RIETE Investigators.
    Haematologica; 2006 Aug; 91(8):1046-51. PubMed ID: 16885044
    [Abstract] [Full Text] [Related]

  • 23. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis.
    Hull RD, Raskob GE, Brant RF, Pineo GF, Valentine KA.
    Arch Intern Med; 2006 Aug; 157(22):2562-8. PubMed ID: 9531224
    [Abstract] [Full Text] [Related]

  • 24. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
    Santamaria MG, Agnelli G, Taliani MR, Prandoni P, Moia M, Bazzan M, Guazzaloca G, Ageno W, Bertoldi A, Silingardi M, Tomasi C, Ambrosio GB, Warfarin Optimal Duration Italian Trial (WODIT) Investigators.
    Thromb Res; 2005 Aug; 116(4):301-6. PubMed ID: 16038714
    [Abstract] [Full Text] [Related]

  • 25. The prevalence of thrombophilia and venous thromboembolism in total knee arthroplasty.
    Chotanaphuti T, Ongnamthip P, Silpipat S, Foojareonyos T, Roschan S, Reumthantong A.
    J Med Assoc Thai; 2007 Jul; 90(7):1342-7. PubMed ID: 17710975
    [Abstract] [Full Text] [Related]

  • 26. The relative contributions of antithrombin III during heparin treatment, and of clinically recognisable risk factors, to early recurrence of venous thromboembolism.
    Gallus AS, Goodall KT, Tillett J, Jackaman J, Wycherley A.
    Thromb Res; 1987 May 15; 46(4):539-53. PubMed ID: 3617012
    [Abstract] [Full Text] [Related]

  • 27. Systemic arterial embolism arising from pulmonary thrombophlebitis.
    Sloop RD, Lium JH.
    Am Surg; 1971 Aug 15; 37(8):503-5. PubMed ID: 5560329
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Laboratory diagnosis of heparin-induced thrombocytopenia and monitoring of alternative anticoagulants.
    Leo A, Winteroll S.
    Clin Diagn Lab Immunol; 2003 Sep 15; 10(5):731-40. PubMed ID: 12965896
    [No Abstract] [Full Text] [Related]

  • 32. Deep Vein Thrombosis.
    Al-Zahrani H, Bates SM, Weitz JI.
    Curr Treat Options Cardiovasc Med; 1999 Jun 15; 1(1):43-54. PubMed ID: 11096468
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Treatment of severe venous thrombo-embolism with intravenous Hirudin (HBW 023): an open pilot study.
    Parent F, Bridey F, Dreyfus M, Musset D, Grimon G, Duroux P, Meyer D, Simonneau G.
    Thromb Haemost; 1993 Sep 01; 70(3):386-8. PubMed ID: 8259534
    [Abstract] [Full Text] [Related]

  • 38. A pilot study of subcutaneous recombinant hirudin (HBW 023) in the treatment of deep vein thrombosis.
    Schiele F, Vuillemenot A, Kramarz P, Kieffer Y, Soria J, Soria C, Camez A, Mirshahi MC, Bassand JP.
    Thromb Haemost; 1994 May 01; 71(5):558-62. PubMed ID: 8091380
    [Abstract] [Full Text] [Related]

  • 39. Subcutaneous recombinant hirudin (HBW 023) versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs: a multicentre prospective dose-ranging randomized trial. International Multicentre Hirudin Study Group.
    Schiele F, Lindgaerde F, Eriksson H, Bassand JP, Wallmark A, Hansson PO, Grollier G, Sjo M, Moia M, Camez A, Smyth V, Walker M.
    Thromb Haemost; 1997 May 01; 77(5):834-8. PubMed ID: 9184388
    [Abstract] [Full Text] [Related]

  • 40. Recombinant hirudin (HBW 023): biological data of ten patients with severe venous thrombo-embolism.
    Bridey F, Dreyfus M, Parent F, Bros A, Fischer AM, Camez A, Simonneau G, Duroux P, Meyer D.
    Am J Hematol; 1995 May 01; 49(1):67-72. PubMed ID: 7741141
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.